3Morrow DA,Rider PM. C -reactive protein inflammation,and coronary risk. Med Clin North Am,2000,84 (1) :149 - 161.
4Muir KW, Weir C J, Alwan W, et al. C - eactive protein and outcome after ischemic stroke. Stroke, 1999,30:981.
5Pasceri V, Willereon JT, Y eh ET. Direct proinflammatory effect of C - reactive protein on human endothelia cells. Circulation. 2000, 102 ( 18 ) : 2165 - 2169.
5MUECK A O,SEEGER H,WALLWIENER D.Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules[].Experimental and Clinical Endocrinology.2001
6DOBRUCKI L W,KALINOWSKI L,DOBRUCKI I T,et al.Statin-stimulated nitric oxide release from endothelium[].Medical Science Monitor.2001
7RIDKER P M,RIFAI N,PFEFFER M A,et al.For the chelesterol and recurrent events (CEAR) investigation, inflammation,pravastain and the risk of coronary events after myocardio infarction in patients with average cholesterol reduction[].Circulation.1988
8ORTEGO M,BUSTOS C,HERNANDEZ-PRESA M A,et al.Atorvastatin reduces NFB activitation and chemokine expression in vascular smooth muscle cells and mononuclear cells[].Atherosclerosis.1999
9SHEPHERD J,COBBE S M,FORDI,et al.Prevention of coronary heart disease with pravaststin in men with hypercholesterol[].The New England Journal of Medicine.1995
10CORSINI A.Fluvastatin: effects beyond cholesterol lowering[].Journal of Cardiovascular Pharmacology.2000
